sur SARTORIUS STED BIO (EPA:DIM)
Availability of the 2024 Universal Registration Document by Sartorius Stedim Biotech
Aubagne-based Sartorius Stedim Biotech announced that its Universal Registration Document for 2024 is now available online. This document includes the evolution of the company's activities for the year 2024, as well as the objectives set for 2025. It also presents the consolidated financial statements as of December 31, 2024. This document is accessible via the company's website, in the investor relations section.
Sartorius Stedim Biotech continues to position itself as a major player in the biopharmaceutical industry thanks to its innovative solutions. In 2024, the company generated sales of around €2.8 billion. With more than 9,900 employees worldwide, the group is continuing its international development, relying on its manufacturing and research sites in Europe, North America and Asia.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SARTORIUS STED BIO